Literature DB >> 16987124

Awareness of rabies risks and knowledge about preventive measures among experienced German travel health advisors.

R Stefan Ross1, Bernd Wolters, Sergei O Viazov, Michael Roggendorf.   

Abstract

BACKGROUND: Every year, millions of people travel to countries where rabies is enzootic. However, the quality of rabies-specific information provided by travel health advisors and the extent of their knowledge about pre- and postexposure prophylaxis have not been examined on a large-scale basis up to now.
METHODS: 5,780 German physicians and pharmacists, who identified themselves as active travel health advisors, were chosen from a database. The selected providers were asked to complete an Internet-based questionnaire. The form requested both demographic information and the assessment of different concrete scenarios, each of which featured individuals seeking pre-travel advice on rabies or appropriate postexposure treatment after returning from abroad.
RESULTS: Overall, 496 physicians and pharmacists completed the questionnaire. Almost all respondents indicated that they would mention the risk of rabies and appropriate preventive measures to long-term travelers and tourists planning to visit rural areas. However, only 35% to 60% of the advisors would provide this information to individuals on business trips, package tours, or travelers in urban centers as well. The assessment of the scenarios yielded 51% to 98% of adequate advice. Potentially harmful decisions included, for instance, the failure to recommend further prophylactic measures after exposure of already vaccinated people or the fact that the necessary postexposure prophylaxis was inappropriately withheld in cases where treatment had been initially delayed.
CONCLUSIONS: Although the participants of this study were well aware of the travel-associated rabies risks and provided adequate information about this health hazard to most of their clients, evident flaws exist regarding the correct assessment of specific situations in pre- and postexposure rabies prophylaxis. Our findings therefore provide important cues on topics that should be more intensely covered during future postgraduate training in travel medicine and also underline the need for more practically orientated, readily available information on specific prophylactic treatment against rabies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987124     DOI: 10.1111/j.1708-8305.2006.00058.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  5 in total

1.  Rabies exposure risk among foreign backpackers in Southeast Asia.

Authors:  Watcharapong Piyaphanee; Prapimporn Shantavasinkul; Weerapong Phumratanaprapin; Piyada Udomchaisakul; Pongdej Wichianprasat; Maneerat Benjavongkulchai; Thitiya Ponam; Terapong Tantawichian
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

2.  Perceptions of rabies risk: a survey of travellers and travel clinics from Canada, Germany, Sweden and the UK.

Authors:  Cinzia Marano; Melissa Moodley; Elaine Melander; Laurence De Moerlooze; Hans D Nothdurft
Journal:  J Travel Med       Date:  2019-02-01       Impact factor: 8.490

3.  Development and Testing of a Clinical Practice Framework for Pharmacists to Assess Patients' Travel-Related Risks: The 5W Approach to Travel Risk Identification.

Authors:  Heidi V J Fernandes; Sherilyn K D Houle
Journal:  Pharmacy (Basel)       Date:  2019-11-26

4.  Establishment and clinical validation of an in-cell-ELISA-based assay for the rapid quantification of Rabies lyssavirus neutralizing antibodies.

Authors:  Lara Schöler; Vu Thuy Khanh Le-Trilling; Ulf Dittmer; Melanie Fiedler; Mirko Trilling
Journal:  PLoS Negl Trop Dis       Date:  2022-05-10

5.  Tour leaders' knowledge of and attitudes toward rabies vaccination, Taiwan.

Authors:  Chiao-Yu Huang; Hsien-Liang Huang; Shao-Yi Cheng; Chia-Wen Lu; Long-Teng Lee; Tai-Yuan Chiu; Kuo-Chin Huang
Journal:  Emerg Infect Dis       Date:  2014-01       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.